☆ 4.7 Article

Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study

VACCINES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Infectious Diseases

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study

Po Ying Chia et al.

Summary: This study found that mRNA vaccines are highly effective at preventing symptomatic and severe COVID-19 associated with B.1.617.2 infection. Vaccination is associated with a faster decline in viral RNA load and a robust serological response.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

添加到收藏夹

Article Geriatrics & Gerontology

Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age-Groups in Japan

Yusuke Asai et al.

Summary: This study analyzed the clinical and epidemiological characteristics of elderly COVID-19 patients in different age groups and found differences among age groups. Most patients had at least one comorbidity, and hypertension was high in all age groups. The proportion of patients with dementia, cardiovascular disease, and cerebrovascular disease increased with age.

GERONTOLOGY (2022)

添加到收藏夹

Letter Infectious Diseases

Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19

Paula de Michelena et al.

JOURNAL OF INFECTION (2022)

添加到收藏夹

Article Infectious Diseases

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study

Anika Singanayagam et al.

Summary: Vaccination reduces the risk of delta variant infection and accelerates viral clearance. However, fully vaccinated individuals with breakthrough infections may still have similar peak viral loads as unvaccinated cases and can efficiently transmit the infection.

LANCET INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Microbiology

SARS-CoV-2 Vaccination and Protection Against Clinical Disease: A Retrospective Study, Bouches-du-Rhone District, Southern France, 2021

Pierre-Edouard Fournier et al.

Summary: A study indicated that within the first 13 days after COVID-19 vaccination, the risk of SARS-CoV-2 infection was significantly higher in patients who had received a single dose compared to those who had received two doses. Full vaccination plays a crucial role in reducing the risk of severe complications from COVID-19, especially in older patients.

FRONTIERS IN MICROBIOLOGY (2022)

添加到收藏夹

Article Immunology

COVID-19 Recovery Patterns Across Alpha (B.1.1.7) and Delta (B.1.617.2) Variants of SARS-CoV-2

Nitya Kumar et al.

Summary: Patients infected with the delta variant of SARS-CoV-2 have a slower recovery as indicated by longer length of stay and higher shedding of the virus compared to alpha variant infections. This trend is consistent in both vaccinated and unvaccinated patients.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

The Impact of SARS-CoV-2 Primary Vaccination in a Cohort of Patients Hospitalized for Acute COVID-19 during Delta Variant Predominance

Dasa Stupica et al.

Summary: This study in Slovenia during the predominance of the Delta variant found that fully vaccinated adult patients with breakthrough infections had a lower likelihood of progressing to critically severe disease and spent less time hospitalized compared to unvaccinated patients.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Duration of viral shedding and culture positivity with postvaccination SARS- CoV-2 delta variant infections

Mark J. Siedner et al.

Summary: Isolation guidelines for SARS-CoV-2 need to be adjusted due to the impact of the delta variant, which shows characteristics such as higher viral load and longer duration of shedding. Prompt testing and isolation are crucial for individuals with symptomatic delta breakthrough infections.

JCI INSIGHT (2022)

添加到收藏夹

Article Emergency Medicine

Vaccination status among patients with the need for emergency hospitalizations related to COVID-19

Ibrahim Toker et al.

Summary: This study investigated the characteristics and mortality rates among hospitalized patients with moderate and severe COVID-19 based on their vaccination status. The results showed that individuals aged 65 and above, unvaccinated individuals, and those with comorbidities had higher mortality rates, while vaccination status, age, and comorbidities were associated with mortality. The study did not evaluate vaccine efficacy, but lower mortality rates were observed among those vaccinated with Coronavac and Pfizer-BioNTech vaccines.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2022)

添加到收藏夹

Article Cell Biology

Immunosenescence and COVID-19

Jacek M. Witkowski et al.

Summary: Ageing is associated with changes in immune system function. These changes may contribute to the increased severity and deadliness of COVID-19 in the elderly. Immunosenescence and inflammaging, which develop over time depending on challenges to the immune system, can affect the reactivity to SARS-CoV-2. Infection with SARS-CoV-2 can also impact the function of the immune system. Immunosenescence and inflammaging can worsen, and be worsened by, SARS-CoV-2 infection.

MECHANISMS OF AGEING AND DEVELOPMENT (2022)

添加到收藏夹

Article Critical Care Medicine

Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study

Paul M. McKeigue et al.

Summary: This study investigated the efficacy of COVID-19 vaccines against severe disease after the delta variant became predominant and whether the efficacy of two doses of the vaccine decreased over time. The results showed that the efficacy of vaccination against severe COVID-19 declined in May 2021 but was reversed in the following month. The most recent data showed that the efficacy of two doses of the ChAdOx1 vaccine was 91% and for mRNA vaccines (Pfizer or Moderna) was 92%. However, the efficacy of the ChAdOx1 vaccine decreased significantly after 20 weeks from the second dose, while the efficacy of mRNA vaccines decreased in the first ten weeks and remained stable thereafter. These findings support the implementation of additional protective measures, such as booster doses, during periods of high transmission rates.

LANCET RESPIRATORY MEDICINE (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022

Mark W. Tenforde et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

COVID-19 vaccination uptake in Belgium: socioeconomic and sociodemographic disparities

L Cavillot et al.

EUROPEAN JOURNAL OF PUBLIC HEALTH (2022)

添加到收藏夹

Article Medicine, General & Internal

Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada

David N. Fisman et al.

Summary: Research in Ontario, Canada, showed that new variants of concern (VOCs) of SARS-CoV-2 have higher risks of hospitalization, ICU admission, and death compared to non-VOC strains, with the Delta variant showing the most pronounced increase in risk.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)

添加到收藏夹

Article Medicine, General & Internal

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity

Mark W. Tenforde et al.

Summary: This study evaluated the association between mRNA COVID-19 vaccines and COVID-19 hospitalization, as well as disease progression to critical illness among hospitalized patients. The results showed that vaccination with mRNA COVID-19 vaccines significantly decreased the likelihood of COVID-19 hospitalization and disease progression to death or mechanical ventilation.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2

Matan Levine-Tiefenbrun et al.

Summary: The study found that the effectiveness of the BNT162b2 vaccine in reducing viral loads of breakthrough infections decreases over time. However, this reduction in viral load can be restored by receiving a third vaccine dose.

NATURE MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons

Stephen M. Kissler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

Rishi R. Goel et al.

Summary: This study found that immune memory to SARS-CoV-2 and its variants remains robust for at least 6 months after mRNA vaccination, with antibodies declining but still detectable in most individuals. mRNA vaccines also induced functional memory B cells and antigen-specific T cells, with recall responses primarily increasing antibody levels in individuals with preexisting immunity.

SCIENCE (2021)

添加到收藏夹

Review Infectious Diseases

Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis

Qiao Liu et al.

Summary: This study included 58 studies, with the effectiveness of a single dose vaccine in preventing SARS-CoV-2 infections at 41% and two doses reaching 85% effectiveness. The vaccines are generally safe and help reduce the incidence of COVID-19-related deaths and severe cases.

INFECTIOUS DISEASES OF POVERTY (2021)

添加到收藏夹

Review Immunology

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape

Dandan Tian et al.

Summary: The Delta variant of the SARS-CoV-2 virus, first reported in India in October 2020 and classified as a variant of concern by the WHO in May 2021, is highly transmissible and associated with increased hospitalization, ICU admission, and mortality rates. It has become the dominant strain in many countries globally.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Immunology

Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword

Li Yin Tan et al.

Summary: COVID-19 caused by SARS-CoV-2 can lead to severe health consequences, including acute respiratory distress syndrome and multi-organ failure, through activation of inflammatory pathways and cytokine storm. Long-term effects, particularly on the brain, are of concern.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Impact of Hospital Strain on Excess Deaths During the COVID-19 Pandemic — United States, July 2020–July 2021

Geoffrey French et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance — COVID-NET, 14 States, January–August 2021

Christopher A. Taylor et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Article Immunology

COVID-19 Breakthrough Infections and Transmission Risk: Real-World Data Analyses from Germany's Largest Public Health Department (Cologne)

Lea Hsu et al.

Summary: The study analyzed data from Cologne residents and found that the number of transmissions from unvaccinated individuals was three times higher than from fully vaccinated patients. Vaccination plays a crucial role in enabling the relaxation of strict pandemic control measures.

VACCINES (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients

Nina Van Goethem et al.

Summary: The study introduces a general conceptual framework for investigating the impact of SARS-CoV-2 variants on the severity of COVID-19 disease. By combining information from different sources, the framework provides a comprehensive understanding of the disease severity among hospitalized patients.

ARCHIVES OF PUBLIC HEALTH (2021)

添加到收藏夹

Article Health Care Sciences & Services

The role of organizational characteristics on the outcome of COVID-19 patients admitted to the ICU in Belgium

Fabio Silvio Taccone et al.

Summary: The study in Belgium found that surge capacity organization, such as ICU overflow or the creation of COVID-19 specific supplementary ICU beds, negatively impacts the outcomes of critically ill COVID-19 patients admitted to ICUs.

LANCET REGIONAL HEALTH-EUROPE (2021)

添加到收藏夹

Article Infectious Diseases

A minimal common outcome measure set for COVID-19 clinical research

J. C. Marshall et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Rapid establishment of a national surveillance of COVID-19 hospitalizations in Belgium

Nina Van Goethem et al.

ARCHIVES OF PUBLIC HEALTH (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Collider bias undermines our understanding of COVID-19 disease risk and severity

Gareth J. Griffith et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.